Evidence map›Paper›PMID 39768868›Full record

ReviewMedicina (Kaunas, Lithuania)2024

Antimicrobials in Orthopedic Infections: Overview of Clinical Perspective and Microbial Resistance.

Bogdan Huzum, Ana Clara Aprotosoaie, Ovidiu Alexa, Paul Dan Sîrbu, Bogdan Puha, Bogdan Veliceasa, Riana Maria Huzum

Abstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bogdan HuzumDepartment of Orthopaedic and Traumatology, Faculty of Medicine "Grigore T. Popa", University of Medicine and Pharmacy of Iasi, 700115 Iasi, Romania.
Ana Clara AprotosoaieFaculty of Pharmacy "Grigore T. Popa", University of Medicine and Pharmacy of Iasi, 700115 Iasi, Romania.
Ovidiu AlexaDepartment of Orthopaedic and Traumatology, Faculty of Medicine "Grigore T. Popa", University of Medicine and Pharmacy of Iasi, 700115 Iasi, Romania.
Paul Dan SîrbuDepartment of Orthopaedic and Traumatology, Faculty of Medicine "Grigore T. Popa", University of Medicine and Pharmacy of Iasi, 700115 Iasi, Romania.ORCID 0000-0003-2806-0649
Bogdan PuhaDepartment of Orthopaedic and Traumatology, Faculty of Medicine "Grigore T. Popa", University of Medicine and Pharmacy of Iasi, 700115 Iasi, Romania.ORCID 0000-0002-9814-7742
Bogdan VeliceasaDepartment of Orthopaedic and Traumatology, Faculty of Medicine "Grigore T. Popa", University of Medicine and Pharmacy of Iasi, 700115 Iasi, Romania.ORCID 0000-0002-9941-3424
Riana Maria HuzumDepartment of Radiology, Faculty of Medicine "Grigore T. Popa", University of Medicine and Pharmacy of Iasi, 700115 Iasi, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orthopedic infections are challenging pathologies that impose a heavy burden on patients and the healthcare system. Antimicrobial therapy is a critical component of the successful management of orthopedic infections, but its effectiveness depends on patient-, surgery-, drug-, and hospital-related factors. The dramatic increase in the emergence of multidrug-resistant microbial strains necessitates new clinical approaches in order to prevent or limit this phenomenon and to ensure a favorable therapeutic outcome. The present paper reviews the currently available antimicrobial strategies in the management of orthopedic infections, highlighting their clinical use related to the occurrence of microbial resistance. Some approaches for reducing antibiotic resistance emergence in orthopedics are also presented. The use of antibiotics tailored to the microorganism's sensitivity profile, patient factors, and pharmacokinetic profile in terms of monotherapy or combinations, the understanding of microbial pathogenicity and resistance patterns, strict control measures in healthcare facilities, the development of new antimicrobial therapies (drugs, devices, technologies), and patient education for improving compliance and tolerance are some of the most important tools for overcoming microbial resistance.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsDrug Resistance, MicrobialDrug Resistance, Multiple, BacterialHumansAnti-Bacterial AgentsAnti-Infective Agentsantibioticsmicrobial resistanceorthopedic infections

Identifiers

PMID39768868
PMCPMC11728363

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.